Literature DB >> 9570639

Plasma thiamine deficiency associated with Alzheimer's disease but not Parkinson's disease.

M Gold1, R A Hauser, M F Chen.   

Abstract

In this study we compared plasma and erythrocyte thiamine levels in a group of patients with idiopathic Parkinson's Disease (iPD) to a group of patients with probable Alzheimer's Disease (pAD). pAD patients had significantly lower plasma thiamine levels (raw and z-score) than iPD patients. A significantly higher number of pAD patients had plasma thiamine deficiencies than iPD patients. The demographics of our patient groups were similar to those reported by other investigators, making age, sex and nutritional status unlikely explanations for our findings. These results suggest that plasma thiamine deficiency is associated with pAD but not with iPD.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9570639     DOI: 10.1023/a:1020678912330

Source DB:  PubMed          Journal:  Metab Brain Dis        ISSN: 0885-7490            Impact factor:   3.584


  53 in total

1.  Semantic memory in DAT, MID and parkinsonism.

Authors:  P Fisher; G Gatterer; W Danielczyk
Journal:  Funct Neurol       Date:  1988 Jul-Sep

Review 2.  Parkinson's disease. The apoptosis hypothesis.

Authors:  G Stern
Journal:  Adv Neurol       Date:  1996

3.  Respiratory chain and mitochondrial DNA in muscle and brain in Parkinson's disease patients.

Authors:  S DiDonato; M Zeviani; P Giovannini; N Savarese; M Rimoldi; C Mariotti; F Girotti; T Caraceni
Journal:  Neurology       Date:  1993-11       Impact factor: 9.910

Review 4.  Cholinergic markers in Alzheimer disease and the autoregulation of acetylcholine release.

Authors:  R Quirion
Journal:  J Psychiatry Neurosci       Date:  1993-11       Impact factor: 6.186

5.  Thiamine therapy in Alzheimer's disease.

Authors:  Y Mimori; H Katsuoka; S Nakamura
Journal:  Metab Brain Dis       Date:  1996-03       Impact factor: 3.584

6.  Plasma and erythrocyte thiamin concentrations in geriatric outpatients.

Authors:  M F Chen; L T Chen; M Gold; H W Boyce
Journal:  J Am Coll Nutr       Date:  1996-06       Impact factor: 3.169

7.  Alterations in glutathione levels in Parkinson's disease and other neurodegenerative disorders affecting basal ganglia.

Authors:  J Sian; D T Dexter; A J Lees; S Daniel; Y Agid; F Javoy-Agid; P Jenner; C D Marsden
Journal:  Ann Neurol       Date:  1994-09       Impact factor: 10.422

8.  Thiamin mono- and pyrophosphatase activities from brain homogenate of Guamanian amyotrophic lateral sclerosis and parkinsonism-dementia patients.

Authors:  U Laforenza; C Patrini; M Poloni; P Mazzarello; M Ceroni; D C Gajdusek; R M Garruto
Journal:  J Neurol Sci       Date:  1992-06       Impact factor: 3.181

9.  Decreased activities of thiamine diphosphatase in frontal and temporal cortex in Alzheimer's disease.

Authors:  V L Rao; J S Richardson; R F Butterworth
Journal:  Brain Res       Date:  1993-12-24       Impact factor: 3.252

Review 10.  The role of oxidative abnormalities in the pathophysiology of Alzheimer's disease.

Authors:  J P Blass; G E Gibson
Journal:  Rev Neurol (Paris)       Date:  1991       Impact factor: 2.607

View more
  16 in total

1.  Correlation of thiamine metabolite levels with cognitive function in the non-demented elderly.

Authors:  Jingwen Lu; Xiaoli Pan; Guoqiang Fei; Changpeng Wang; Lei Zhao; Shaoming Sang; Huimin Liu; Meng Liu; Hui Wang; Zhiliang Wang; Chunjiu Zhong
Journal:  Neurosci Bull       Date:  2015-12       Impact factor: 5.203

2.  Size of mamillary bodies in health and disease: useful measurements in neuroradiological diagnosis of Wernicke's encephalopathy.

Authors:  D Sheedy; A Lara; T Garrick; C Harper
Journal:  Alcohol Clin Exp Res       Date:  1999-10       Impact factor: 3.455

Review 3.  Membrane Aging as the Real Culprit of Alzheimer's Disease: Modification of a Hypothesis.

Authors:  Qiujian Yu; Chunjiu Zhong
Journal:  Neurosci Bull       Date:  2017-11-24       Impact factor: 5.203

Review 4.  Thiamine Deficiency and Neurodegeneration: the Interplay Among Oxidative Stress, Endoplasmic Reticulum Stress, and Autophagy.

Authors:  Dexiang Liu; Zunji Ke; Jia Luo
Journal:  Mol Neurobiol       Date:  2016-09-05       Impact factor: 5.590

5.  Exposure to pyrithiamine increases β-amyloid accumulation, Tau hyperphosphorylation, and glycogen synthase kinase-3 activity in the brain.

Authors:  Jing Zhao; Xiaojing Sun; Zhe Yu; Xiaoli Pan; Fenghua Gu; Jia Chen; Wenxin Dong; Lei Zhao; Chunjiu Zhong
Journal:  Neurotox Res       Date:  2010-06-22       Impact factor: 3.911

Review 6.  Vitamin B1 (thiamine) and dementia.

Authors:  Gary E Gibson; Joseph A Hirsch; Pasquale Fonzetti; Barry D Jordan; Rosanna T Cirio; Jessica Elder
Journal:  Ann N Y Acad Sci       Date:  2016-03-11       Impact factor: 5.691

Review 7.  Abnormal thiamine-dependent processes in Alzheimer's Disease. Lessons from diabetes.

Authors:  Gary E Gibson; Joseph A Hirsch; Rosanna T Cirio; Barry D Jordan; Pasquale Fonzetti; Jessica Elder
Journal:  Mol Cell Neurosci       Date:  2012-09-13       Impact factor: 4.314

8.  Benfotiamine treatment activates the Nrf2/ARE pathway and is neuroprotective in a transgenic mouse model of tauopathy.

Authors:  Victor Tapias; Shari Jainuddin; Manuj Ahuja; Cliona Stack; Ceyhan Elipenahli; Julie Vignisse; Meri Gerges; Natalia Starkova; Hui Xu; Anatoly A Starkov; Lucien Bettendorff; Dmitry M Hushpulian; Natalya A Smirnova; Irina G Gazaryan; Navneet A Kaidery; Sushama Wakade; Noel Y Calingasan; Bobby Thomas; Gary E Gibson; Magali Dumont; M Flint Beal
Journal:  Hum Mol Genet       Date:  2018-08-15       Impact factor: 6.150

9.  Measurement of Blood Thiamine Metabolites for Alzheimer's Disease Diagnosis.

Authors:  Xiaoli Pan; Guoqiang Fei; Jingwen Lu; Lirong Jin; Shumei Pan; Zhichun Chen; Changpeng Wang; Shaoming Sang; Huimin Liu; Weihong Hu; Hua Zhang; Hui Wang; Zhiliang Wang; Qiong Tan; Yan Qin; Qunying Zhang; Xueping Xie; Yong Ji; Donghong Cui; Xiaohua Gu; Jun Xu; Yuguo Yu; Chunjiu Zhong
Journal:  EBioMedicine       Date:  2015-11-26       Impact factor: 8.143

Review 10.  Acetyl-CoA the key factor for survival or death of cholinergic neurons in course of neurodegenerative diseases.

Authors:  Andrzej Szutowicz; Hanna Bielarczyk; Agnieszka Jankowska-Kulawy; Tadeusz Pawełczyk; Anna Ronowska
Journal:  Neurochem Res       Date:  2013-05-16       Impact factor: 3.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.